Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial management strategies for dyspepsia.

B C Delaney1, P Moayyedi, D Forman

  • 1Department of Primary Care and General Practice, Primary Care and Clinical Sciences Building, The University of Birmingham, Edgbaston, Birmingham, West Midlands, UK, B15 2TT. b.c.delaney@bham.ac.uk

The Cochrane Database of Systematic Reviews
|June 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining Use of Corticosteroids for Crohn's Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial.

Journal of the Canadian Association of Gastroenterology·2021
Same author

Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Letter: NICE referral criteria for lower gastrointestinal alarm features - not ideal but not poor either. Authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.

Alimentary pharmacology & therapeutics·2017
Same author

Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care.

Alimentary pharmacology & therapeutics·2016
Same author

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Gut·2016

Proton pump inhibitors (PPIs) effectively treat dyspepsia symptoms. Helicobacter pylori (H. pylori) eradication therapy offers a cost-effective management strategy, potentially improving outcomes compared to acid suppression alone.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Evidence-Based Medicine

Background:

  • Dyspepsia management strategies require evaluation for effectiveness and cost-efficiency.
  • Dyspepsia encompasses epigastric pain and heartburn, necessitating varied treatment approaches.

Purpose of the Study:

  • To assess the effectiveness, acceptability, and cost-effectiveness of different initial management strategies for dyspepsia.
  • Compare pharmacological therapy, early endoscopy, Helicobacter pylori (H. pylori) testing, and eradication therapy.

Main Methods:

  • Systematic review of randomized controlled trials in primary care patients with dyspepsia.
  • Data collection focused on symptom relief, quality of life, and healthcare resource utilization.

Main Results:

Related Experiment Videos

  • Proton pump inhibitors (PPIs) demonstrated superior efficacy over H2 receptor antagonists and antacids.
  • H. pylori 'test and treat' strategies may be as effective as endoscopy-based management and reduce costs.
  • Early endoscopy showed a marginal benefit in reducing recurrent dyspeptic symptoms compared to initial prescribing.

Conclusions:

  • PPIs are effective for dyspepsia, though trial populations may include gastro-oesophageal reflux disease patients.
  • Early investigation via endoscopy or H. pylori testing may benefit select dyspepsia patients.
  • Further analysis including individual patient data meta-analysis is planned to refine economic and subgroup findings.